Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
The development of a dose-dependent cardiomyopathy is the main limitation for the use of doxorubicin in chemotherapy protocols in both humans and animals. In this setting, the global myocardial function may be compromised resulting in signs of congestive heart failure. In this study, we investigated...
Guardado en:
Autores principales: | Sousa,MG, Paulino-Junior,D, Pascon,JPE, Pereira-Neto,GB, Carareto,R, Camacho,AA |
---|---|
Lenguaje: | English |
Publicado: |
Facultad de Ciencias Veterinarias, Universidad Austral de Chile
2014
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0301-732X2014000100009 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tei index of myocardial performance in conscious healthy Beagles
por: Sousa,MG, et al.
Publicado: (2016) -
Impacto cardiovascular secundario a la terapia para el control del cáncer
por: Ríos,Juvenal A., et al.
Publicado: (2020) -
Genetic basis of anthracyclines cardiotoxicity: Literature review
por: M. Yu. Sinitsky, et al.
Publicado: (2021) -
Assessment of Myocardial Work in Cancer Therapy-Related Cardiac Dysfunction and Analysis of CTRCD Prediction by Echocardiography
por: Jingyuan Guan, et al.
Publicado: (2021) -
<i>POLRMT</i> as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
por: Alejandro Velasco-Ruiz, et al.
Publicado: (2021)